110 related articles for article (PubMed ID: 18250063)
1. [Expressions of homeobox transcription factor-2 and E-cadherin in gastric carcinoma and their clinical significance].
Ge J; Chen ZH; Chen ZK; Yuan WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):279-1281. PubMed ID: 18250063
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
[TBL] [Abstract][Full Text] [Related]
3. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
[TBL] [Abstract][Full Text] [Related]
4. [Expression of guanylyl cyclase-c and caudal type homeobox transcription factor 2 in human gastric cancer and precursor lesions].
Zhu HJ; Xu Z; Mao ZB; Zhang JF; Zhang JG; Pan ZP
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3418-21. PubMed ID: 19159573
[TBL] [Abstract][Full Text] [Related]
5. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Cdx-2 homeobox gene in intestinal metaplasia and gastric adenocarcinoma].
Paik CH; Han DS; Lee SH; Chung YW; Kim JP; Sohn JH; Hahm JS; Oh YH; Park YU
Korean J Gastroenterol; 2004 Oct; 44(4):186-92. PubMed ID: 15505429
[TBL] [Abstract][Full Text] [Related]
7. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
Fan Z; Li J; Dong B; Huang X
Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
Zhao Y; Jin X; Li N; Li J; Qian J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1390-1395. PubMed ID: 27777204
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
[TBL] [Abstract][Full Text] [Related]
12. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
15. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
16. Protein expression status in mucosal and submucosal portions of early gastric cancers and their predictive value for lymph node metastasis.
Lee KB; Park DJ; Choe G; Kim HH; Kim WH; Lee HS
APMIS; 2013 Oct; 121(10):926-37. PubMed ID: 23758612
[TBL] [Abstract][Full Text] [Related]
17. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
18. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Gao H; Lan X; Li S; Xue Y
Tumour Biol; 2017 May; 39(5):1010428317698368. PubMed ID: 28459196
[TBL] [Abstract][Full Text] [Related]
19. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations.
Schildberg CW; Abba M; Merkel S; Agaimy A; Dimmler A; Schlabrakowski A; Croner R; Leupold JH; Hohenberger W; Allgayer H
Adv Med Sci; 2014 Mar; 59(1):142-6. PubMed ID: 24797991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
